跳至主要内容
临床试验/IRCT20201220049774N3
IRCT20201220049774N3招募中3 期

Evaluation of the effect of curcumin-piperine supplement on damage indicators in septic patients admitted to the intensive care unit

Mashhad University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age between 18 and 80 years
  • Having sepsis and being admitted to the intensive care unit
  • Signing an informed consent form

排除标准

  • Pregnancy and lactation
  • History of allergy to turmeric and curcumin products
  • Age under 18 years
  • HIV patients
  • Member transplant history
  • Rheumatic or autoimmune disease
  • Patients treated with immunosuppressive drugs
  • Patients treated with corticosteroids
  • Radiotherapy
  • Solid or malignant tumor
  • Concomitant use of any supplement with antioxidant or anti-inflammatory effect or immune system regulator
  • Patients without oral / nasal gastrointestinal tract
  • White blood cell count less than 1000 / microliter

研究者

相似试验